AstraZeneca to build $2.5B research hub in Beijing

AstraZeneca unveils China investment despite ex boss detention

London (AFP) Mar 21, 2025 British pharmaceutical giant AstraZeneca on Friday announced plans to invest $2.5 billion in China, despite the detention there of its former head of operations over alleged illegal activity. The investment over the next five years will fund the company's sixth global strategic research and development centre and grow its Beijing workforce to 1,700 employees, AstraZeneca said in a statement.

AstraZeneca to invest £2bn in Beijing amid China investigation

Pharmaceutical giant scrambles to contain scandal over alleged illegal drug imports

AstraZeneca invests US$2.5 billion in Beijing, undeterred by probe

AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China just months after the company’s top executive there was detained by authorities.

AZ builds in China, as J&J ramps up its US investments

AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.

AstraZeneca to build $2.5B research hub in Beijing

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational pharmaceutical announced Friday.